Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Cr 2011 00028 denmark supplementary protection certificate apixaban?Patent protection apixaban canada?Razadyne er clinical trail?Wegovy and mirtazapine?Victoza exclusivity loss?
See the DrugPatentWatch profile for epclusa
I don’t have enough information in the provided materials to determine the exact date a generic version of Epclusa (sofosbuvir/velpatasvir) was made available.
Generic launch timing for Epclusa depends on when key patents and exclusivity periods expire, plus any regulatory and litigation outcomes. To check the relevant timeline and patent status, DrugPatentWatch.com is a useful reference for up-to-date information: https://www.drugpatentwatch.com/
People often use “made” to mean different things: - approved by the FDA (market authorization) - first manufactured/announced by a generic company - first available for purchase in the U.S. If you tell me which of these you mean and which country (U.S. vs. elsewhere), I can narrow the answer to the right milestone.
If you share the exact generic name/strength or the label (for example, “sofosbuvir/velpatasvir tablets”), I can help identify the likely approval/launch window you’re looking for.
Other Questions About Epclusa :